Influence of 7-nitroindazole and NG-nitro-L-arginine on the anticonvulsant activity of loreclezole in maximal electroshock-induced seizures in mice
The aim of the study was to determine the effects of 7-nitroindazole (7NI - a preferential neuronal nitric oxide synthase [NOS] inhibitor) and NG-nitro-L-arginine (NNA – a non-selective NOS inhibitor) on the anticonvulsant action of loreclezole (LCZ – an innovative antiepileptic drug) in maximal ele...
Gespeichert in:
| Veröffentlicht in: | Journal of pre-clinical and clinical research 2007-01, Vol.1 (2), p.146 |
|---|---|
| Hauptverfasser: | , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | 2 |
| container_start_page | 146 |
| container_title | Journal of pre-clinical and clinical research |
| container_volume | 1 |
| creator | Łuszczki, Jarogniew J Zadrożniak, Anna Barcicka-Kłosowska, Beata Bednarski, Jerzy Misiuta-Krzesińska, Marta Filip, Damian Zwoliński, Jakub Czernecki, Remigiusz |
| description | The aim of the study was to determine the effects of 7-nitroindazole (7NI - a preferential neuronal nitric oxide synthase [NOS] inhibitor) and NG-nitro-L-arginine (NNA – a non-selective NOS inhibitor) on the anticonvulsant action of loreclezole (LCZ – an innovative antiepileptic drug) in maximal electroshock-induced seizures (MES) in mice. Electroconvulsions were produced in mice by means of an alternating current (50 Hz, 500 V, 25 mA, administered by ear-clip electrodes, 0.2-s stimulus duration, tonic hind limb extension taken as the end point). The anticonvulsant action of LCZ in the MES test was expressed as the median effective dose (ED50 value) of the drug, protecting 50% of animals tested against MES-induced seizures. The acute adverse-effect potentials of LCZ in combination with 7NI and NNA were evaluated in the chimney test (motor coordination), step-through passive avoidance task (longterm memory), and grip-strength test (skeletal muscular strength) in mice. Results indicate that 7NI (50 mg/kg; i.p.) significantly enhanced the anticonvulsant action of LCZ by reducing its ED50 value from 108.9 mg/kg to 60.5 mg/kg (P |
| format | Article |
| fullrecord | <record><control><sourceid>proquest</sourceid><recordid>TN_cdi_proquest_journals_2576696419</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2576696419</sourcerecordid><originalsourceid>FETCH-proquest_journals_25766964193</originalsourceid><addsrcrecordid>eNqNjd1OAjEQRhsjiUR5h0m8bsKC7e5eEwUT45X3pOnOykCZYn8I8Bq8sAV5AOdmvsx3cuZODKumbWStKn1_y5Npqx7EKMb1uEyjtVL1UJzfuXcZ2SL4HmrJlIIn7szJOwTDHXzO_47yQ5rwTUxcUIa0utSJrOd9drFEMDbRntLxYnI-oHV4tRDD1hxoaxygQ1tcceXtRpY32WIHEemUA8YrSBafxKA3LuLoth_F89vr12whd8H_ZIxpufY5cKmWE1Vr3eqXqp3-j_oFYFtapw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2576696419</pqid></control><display><type>article</type><title>Influence of 7-nitroindazole and NG-nitro-L-arginine on the anticonvulsant activity of loreclezole in maximal electroshock-induced seizures in mice</title><source>DOAJ Directory of Open Access Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Łuszczki, Jarogniew J ; Zadrożniak, Anna ; Barcicka-Kłosowska, Beata ; Bednarski, Jerzy ; Misiuta-Krzesińska, Marta ; Filip, Damian ; Zwoliński, Jakub ; Czernecki, Remigiusz</creator><creatorcontrib>Łuszczki, Jarogniew J ; Zadrożniak, Anna ; Barcicka-Kłosowska, Beata ; Bednarski, Jerzy ; Misiuta-Krzesińska, Marta ; Filip, Damian ; Zwoliński, Jakub ; Czernecki, Remigiusz</creatorcontrib><description>The aim of the study was to determine the effects of 7-nitroindazole (7NI - a preferential neuronal nitric oxide synthase [NOS] inhibitor) and NG-nitro-L-arginine (NNA – a non-selective NOS inhibitor) on the anticonvulsant action of loreclezole (LCZ – an innovative antiepileptic drug) in maximal electroshock-induced seizures (MES) in mice. Electroconvulsions were produced in mice by means of an alternating current (50 Hz, 500 V, 25 mA, administered by ear-clip electrodes, 0.2-s stimulus duration, tonic hind limb extension taken as the end point). The anticonvulsant action of LCZ in the MES test was expressed as the median effective dose (ED50 value) of the drug, protecting 50% of animals tested against MES-induced seizures. The acute adverse-effect potentials of LCZ in combination with 7NI and NNA were evaluated in the chimney test (motor coordination), step-through passive avoidance task (longterm memory), and grip-strength test (skeletal muscular strength) in mice. Results indicate that 7NI (50 mg/kg; i.p.) significantly enhanced the anticonvulsant action of LCZ by reducing its ED50 value from 108.9 mg/kg to 60.5 mg/kg (P<0.05). Similarly, 7NI at the lower dose of 25 mg/kg also enhanced the antiseizure action of LCZ by lowering the ED50 value of LCZ from 108.9 mg/kg to 82.7 mg/kg, although the results did not attain statistical significance. In contrast, NNA (40 mg/kg; i.p.) attenuated the anticonvulsant effects of LCZ by increasing its ED50 value from 108.9 mg/kg to 137.4 mg/kg; however, statistical analysis of the data revealed no significance between both ED50 values. Moreover, none of the examined combinations of LCZ with 7NI and NNA affected motor coordination, long-term memory, or skeletal muscular strength in the mice. Based on this preclinical study, one may conclude that 7NI significantly enhanced, whereas NNA attenuated the antiseizure affects of LCZ against MES-induced seizures in mice.</description><identifier>ISSN: 1898-2395</identifier><identifier>EISSN: 1898-7516</identifier><language>eng</language><publisher>Lublin: Institute of Rural Health</publisher><subject>Anticonvulsants ; Convulsions & seizures ; Drug dosages ; Motor ability ; Muscle strength ; Nitric oxide</subject><ispartof>Journal of pre-clinical and clinical research, 2007-01, Vol.1 (2), p.146</ispartof><rights>2007. This work is published under https://creativecommons.org/licenses/by-nc/3.0/pl/deed.en (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780</link.rule.ids></links><search><creatorcontrib>Łuszczki, Jarogniew J</creatorcontrib><creatorcontrib>Zadrożniak, Anna</creatorcontrib><creatorcontrib>Barcicka-Kłosowska, Beata</creatorcontrib><creatorcontrib>Bednarski, Jerzy</creatorcontrib><creatorcontrib>Misiuta-Krzesińska, Marta</creatorcontrib><creatorcontrib>Filip, Damian</creatorcontrib><creatorcontrib>Zwoliński, Jakub</creatorcontrib><creatorcontrib>Czernecki, Remigiusz</creatorcontrib><title>Influence of 7-nitroindazole and NG-nitro-L-arginine on the anticonvulsant activity of loreclezole in maximal electroshock-induced seizures in mice</title><title>Journal of pre-clinical and clinical research</title><description>The aim of the study was to determine the effects of 7-nitroindazole (7NI - a preferential neuronal nitric oxide synthase [NOS] inhibitor) and NG-nitro-L-arginine (NNA – a non-selective NOS inhibitor) on the anticonvulsant action of loreclezole (LCZ – an innovative antiepileptic drug) in maximal electroshock-induced seizures (MES) in mice. Electroconvulsions were produced in mice by means of an alternating current (50 Hz, 500 V, 25 mA, administered by ear-clip electrodes, 0.2-s stimulus duration, tonic hind limb extension taken as the end point). The anticonvulsant action of LCZ in the MES test was expressed as the median effective dose (ED50 value) of the drug, protecting 50% of animals tested against MES-induced seizures. The acute adverse-effect potentials of LCZ in combination with 7NI and NNA were evaluated in the chimney test (motor coordination), step-through passive avoidance task (longterm memory), and grip-strength test (skeletal muscular strength) in mice. Results indicate that 7NI (50 mg/kg; i.p.) significantly enhanced the anticonvulsant action of LCZ by reducing its ED50 value from 108.9 mg/kg to 60.5 mg/kg (P<0.05). Similarly, 7NI at the lower dose of 25 mg/kg also enhanced the antiseizure action of LCZ by lowering the ED50 value of LCZ from 108.9 mg/kg to 82.7 mg/kg, although the results did not attain statistical significance. In contrast, NNA (40 mg/kg; i.p.) attenuated the anticonvulsant effects of LCZ by increasing its ED50 value from 108.9 mg/kg to 137.4 mg/kg; however, statistical analysis of the data revealed no significance between both ED50 values. Moreover, none of the examined combinations of LCZ with 7NI and NNA affected motor coordination, long-term memory, or skeletal muscular strength in the mice. Based on this preclinical study, one may conclude that 7NI significantly enhanced, whereas NNA attenuated the antiseizure affects of LCZ against MES-induced seizures in mice.</description><subject>Anticonvulsants</subject><subject>Convulsions & seizures</subject><subject>Drug dosages</subject><subject>Motor ability</subject><subject>Muscle strength</subject><subject>Nitric oxide</subject><issn>1898-2395</issn><issn>1898-7516</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><sourceid>BENPR</sourceid><recordid>eNqNjd1OAjEQRhsjiUR5h0m8bsKC7e5eEwUT45X3pOnOykCZYn8I8Bq8sAV5AOdmvsx3cuZODKumbWStKn1_y5Npqx7EKMb1uEyjtVL1UJzfuXcZ2SL4HmrJlIIn7szJOwTDHXzO_47yQ5rwTUxcUIa0utSJrOd9drFEMDbRntLxYnI-oHV4tRDD1hxoaxygQ1tcceXtRpY32WIHEemUA8YrSBafxKA3LuLoth_F89vr12whd8H_ZIxpufY5cKmWE1Vr3eqXqp3-j_oFYFtapw</recordid><startdate>20070101</startdate><enddate>20070101</enddate><creator>Łuszczki, Jarogniew J</creator><creator>Zadrożniak, Anna</creator><creator>Barcicka-Kłosowska, Beata</creator><creator>Bednarski, Jerzy</creator><creator>Misiuta-Krzesińska, Marta</creator><creator>Filip, Damian</creator><creator>Zwoliński, Jakub</creator><creator>Czernecki, Remigiusz</creator><general>Institute of Rural Health</general><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>PHGZM</scope><scope>PHGZT</scope><scope>PIMPY</scope><scope>PKEHL</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope></search><sort><creationdate>20070101</creationdate><title>Influence of 7-nitroindazole and NG-nitro-L-arginine on the anticonvulsant activity of loreclezole in maximal electroshock-induced seizures in mice</title><author>Łuszczki, Jarogniew J ; Zadrożniak, Anna ; Barcicka-Kłosowska, Beata ; Bednarski, Jerzy ; Misiuta-Krzesińska, Marta ; Filip, Damian ; Zwoliński, Jakub ; Czernecki, Remigiusz</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-proquest_journals_25766964193</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><topic>Anticonvulsants</topic><topic>Convulsions & seizures</topic><topic>Drug dosages</topic><topic>Motor ability</topic><topic>Muscle strength</topic><topic>Nitric oxide</topic><toplevel>online_resources</toplevel><creatorcontrib>Łuszczki, Jarogniew J</creatorcontrib><creatorcontrib>Zadrożniak, Anna</creatorcontrib><creatorcontrib>Barcicka-Kłosowska, Beata</creatorcontrib><creatorcontrib>Bednarski, Jerzy</creatorcontrib><creatorcontrib>Misiuta-Krzesińska, Marta</creatorcontrib><creatorcontrib>Filip, Damian</creatorcontrib><creatorcontrib>Zwoliński, Jakub</creatorcontrib><creatorcontrib>Czernecki, Remigiusz</creatorcontrib><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>ProQuest Central (New)</collection><collection>ProQuest One Academic (New)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Middle East (New)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><jtitle>Journal of pre-clinical and clinical research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Łuszczki, Jarogniew J</au><au>Zadrożniak, Anna</au><au>Barcicka-Kłosowska, Beata</au><au>Bednarski, Jerzy</au><au>Misiuta-Krzesińska, Marta</au><au>Filip, Damian</au><au>Zwoliński, Jakub</au><au>Czernecki, Remigiusz</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Influence of 7-nitroindazole and NG-nitro-L-arginine on the anticonvulsant activity of loreclezole in maximal electroshock-induced seizures in mice</atitle><jtitle>Journal of pre-clinical and clinical research</jtitle><date>2007-01-01</date><risdate>2007</risdate><volume>1</volume><issue>2</issue><spage>146</spage><pages>146-</pages><issn>1898-2395</issn><eissn>1898-7516</eissn><abstract>The aim of the study was to determine the effects of 7-nitroindazole (7NI - a preferential neuronal nitric oxide synthase [NOS] inhibitor) and NG-nitro-L-arginine (NNA – a non-selective NOS inhibitor) on the anticonvulsant action of loreclezole (LCZ – an innovative antiepileptic drug) in maximal electroshock-induced seizures (MES) in mice. Electroconvulsions were produced in mice by means of an alternating current (50 Hz, 500 V, 25 mA, administered by ear-clip electrodes, 0.2-s stimulus duration, tonic hind limb extension taken as the end point). The anticonvulsant action of LCZ in the MES test was expressed as the median effective dose (ED50 value) of the drug, protecting 50% of animals tested against MES-induced seizures. The acute adverse-effect potentials of LCZ in combination with 7NI and NNA were evaluated in the chimney test (motor coordination), step-through passive avoidance task (longterm memory), and grip-strength test (skeletal muscular strength) in mice. Results indicate that 7NI (50 mg/kg; i.p.) significantly enhanced the anticonvulsant action of LCZ by reducing its ED50 value from 108.9 mg/kg to 60.5 mg/kg (P<0.05). Similarly, 7NI at the lower dose of 25 mg/kg also enhanced the antiseizure action of LCZ by lowering the ED50 value of LCZ from 108.9 mg/kg to 82.7 mg/kg, although the results did not attain statistical significance. In contrast, NNA (40 mg/kg; i.p.) attenuated the anticonvulsant effects of LCZ by increasing its ED50 value from 108.9 mg/kg to 137.4 mg/kg; however, statistical analysis of the data revealed no significance between both ED50 values. Moreover, none of the examined combinations of LCZ with 7NI and NNA affected motor coordination, long-term memory, or skeletal muscular strength in the mice. Based on this preclinical study, one may conclude that 7NI significantly enhanced, whereas NNA attenuated the antiseizure affects of LCZ against MES-induced seizures in mice.</abstract><cop>Lublin</cop><pub>Institute of Rural Health</pub><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1898-2395 |
| ispartof | Journal of pre-clinical and clinical research, 2007-01, Vol.1 (2), p.146 |
| issn | 1898-2395 1898-7516 |
| language | eng |
| recordid | cdi_proquest_journals_2576696419 |
| source | DOAJ Directory of Open Access Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals |
| subjects | Anticonvulsants Convulsions & seizures Drug dosages Motor ability Muscle strength Nitric oxide |
| title | Influence of 7-nitroindazole and NG-nitro-L-arginine on the anticonvulsant activity of loreclezole in maximal electroshock-induced seizures in mice |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-22T00%3A22%3A23IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Influence%20of%207-nitroindazole%20and%20NG-nitro-L-arginine%20on%20the%20anticonvulsant%20activity%20of%20loreclezole%20in%20maximal%20electroshock-induced%20seizures%20in%20mice&rft.jtitle=Journal%20of%20pre-clinical%20and%20clinical%20research&rft.au=%C5%81uszczki,%20Jarogniew%20J&rft.date=2007-01-01&rft.volume=1&rft.issue=2&rft.spage=146&rft.pages=146-&rft.issn=1898-2395&rft.eissn=1898-7516&rft_id=info:doi/&rft_dat=%3Cproquest%3E2576696419%3C/proquest%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2576696419&rft_id=info:pmid/&rfr_iscdi=true |